China Universal Asset Management Company’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63K | Buy |
16,290
+842
| +5% | +$3.26K | 0.01% | 403 |
|
|
2025
Q1 | $77.2K | Buy |
15,448
+367
| +2% | +$1.84K | 0.01% | 380 |
|
|
2024
Q4 | $109K | Buy |
+15,081
| New | +$109K | 0.01% | 381 |
|
|
2023
Q4 | – | Sell |
-1,354
| Closed | -$3.52K | – | 432 |
|
|
2023
Q3 | $3.52K | Buy |
1,354
+708
| +110% | +$1.84K | ﹤0.01% | 408 |
|
|
2023
Q2 | $2.28K | Sell |
646
-22
| -3% | -$78 | ﹤0.01% | 421 |
|
|
2023
Q1 | $2.82K | Buy |
668
+169
| +34% | +$713 | ﹤0.01% | 419 |
|
|
2022
Q4 | $8.21K | Buy |
499
+40
| +9% | +$658 | ﹤0.01% | 245 |
|
|
2022
Q3 | $6K | Buy |
+459
| New | +$6K | ﹤0.01% | 245 |
|